Trial Profile
Long-term safety and efficacy of nonacog alfa in patients with hemophilia B for prophylaxic or on demand treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jul 2017
Price :
$35
*
At a glance
- Drugs Nonacog alfa (Primary)
- Indications Haemophilia B
- Focus Adverse reactions; Therapeutic Use
- 10 Jul 2017 New trial record